Aflac Incorporated (NYSE:AFL – Get Free Report) major shareholder Post Holdings Co. Ltd. Japan sold 19,000 shares of the stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $110.47, for a total transaction of $2,098,930.00. Following the completion of the transaction, the insider directly owned 52,186,100 shares of the company’s stock, valued at $5,764,998,467. This trade represents a 0.04% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
Post Holdings Co. Ltd. Japan also recently made the following trade(s):
- On Wednesday, March 11th, Post Holdings Co. Ltd. Japan sold 18,100 shares of Aflac stock. The stock was sold at an average price of $109.53, for a total transaction of $1,982,493.00.
- On Monday, March 9th, Post Holdings Co. Ltd. Japan sold 17,300 shares of Aflac stock. The shares were sold at an average price of $109.62, for a total value of $1,896,426.00.
- On Friday, March 6th, Post Holdings Co. Ltd. Japan sold 19,100 shares of Aflac stock. The shares were sold at an average price of $110.77, for a total value of $2,115,707.00.
- On Thursday, March 5th, Post Holdings Co. Ltd. Japan sold 19,300 shares of Aflac stock. The stock was sold at an average price of $110.96, for a total value of $2,141,528.00.
Aflac Price Performance
Aflac stock opened at $108.73 on Friday. The business has a 50 day simple moving average of $111.63 and a 200 day simple moving average of $110.30. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.11 and a quick ratio of 0.11. The company has a market capitalization of $56.14 billion, a PE ratio of 15.80, a price-to-earnings-growth ratio of 3.59 and a beta of 0.66. Aflac Incorporated has a one year low of $96.95 and a one year high of $119.32.
Key Stories Impacting Aflac
Here are the key news stories impacting Aflac this week:
- Positive Sentiment: New distribution deal: Aflac announced a partnership with Empower Brokerage to distribute supplemental-insurance products, which should broaden channels for sales and support premium growth over time. Read More.
- Neutral Sentiment: Earnings/fundamentals context: Aflac’s Feb. 4 quarter showed an EPS miss and revenue decline year-over-year; consensus remains a “Hold” with an average target around $111. That keeps analysts cautious and caps upside absent clearer improvement in top-line trends.
- Neutral Sentiment: Human-interest coverage: Aflac ran a feature on a policyholder’s cancer journey (brand/PR positive but unlikely to move the stock materially). Read More.
- Negative Sentiment: Director insider sale: Director Charles D. Lake II sold 15,590 shares (avg. ~$109.93) on Mar. 11. Insider sales can be read negatively by the market even if motivated by personal reasons; SEC Form 4 filed. Read More.
- Negative Sentiment: Major shareholder trimming: Post Holdings (Japan) has executed several small block sales (multiple ~17k–19k-share trades across Mar. 5–11). Sales are small relative to its >10% stake but add supply and suggest portfolio rebalancing rather than confidence-boosting buying. Read More.
- Negative Sentiment: Cybersecurity incident disclosed: Media reports say Aflac confirmed a cybersecurity breach; details remain limited. Potential data, remediation costs, regulatory follow-ups or client impact make this the most direct near‑term operational risk in the headlines. Read More.
Wall Street Analyst Weigh In
Several equities research analysts have recently weighed in on AFL shares. Raymond James Financial reaffirmed an “outperform” rating and issued a $119.00 target price (up from $110.00) on shares of Aflac in a report on Tuesday, December 30th. Morgan Stanley set a $120.00 price target on shares of Aflac in a research report on Monday, December 15th. Wells Fargo & Company upped their price objective on shares of Aflac from $109.00 to $118.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 25th. Wall Street Zen lowered shares of Aflac from a “hold” rating to a “sell” rating in a report on Saturday, February 28th. Finally, Weiss Ratings reiterated a “buy (b+)” rating on shares of Aflac in a research note on Monday, December 22nd. Three equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $111.73.
Read Our Latest Research Report on AFL
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the business. Brighton Jones LLC grew its holdings in Aflac by 64.4% during the 4th quarter. Brighton Jones LLC now owns 14,570 shares of the financial services provider’s stock worth $1,507,000 after acquiring an additional 5,708 shares during the last quarter. Bison Wealth LLC raised its stake in shares of Aflac by 4.3% in the fourth quarter. Bison Wealth LLC now owns 4,402 shares of the financial services provider’s stock worth $455,000 after acquiring an additional 183 shares during the last quarter. Savant Capital LLC raised its stake in shares of Aflac by 5.4% in the second quarter. Savant Capital LLC now owns 18,137 shares of the financial services provider’s stock worth $1,913,000 after acquiring an additional 930 shares during the last quarter. Penserra Capital Management LLC grew its stake in shares of Aflac by 9.3% during the second quarter. Penserra Capital Management LLC now owns 2,716 shares of the financial services provider’s stock valued at $286,000 after purchasing an additional 230 shares during the last quarter. Finally, Midwest Trust Co bought a new stake in shares of Aflac during the second quarter valued at approximately $899,000. 67.44% of the stock is owned by institutional investors.
Aflac Company Profile
Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.
Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.
Further Reading
- Five stocks we like better than Aflac
- A personal warning from Martin Weiss (Please read)
- SpaceX IPO Confirmed: Claim Your Stake Today
- Iran isn’t the real war
- This coin has everything going for it
- Only 500 people today…
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
